1.2.40.0.34.10.170/static-2016-11-24T000000: Unterschied zwischen den Versionen

Aus HL7 Austria MediaWiki
Wechseln zu: Navigation, Suche
[unmarkierte Version][unmarkierte Version]
(Automated ADBot page content)
(Automated ADBot page content)
Zeile 1: Zeile 1:
  
−
<table xmlns="http://www.w3.org/1999/xhtml" class="artdecor" width="100%" border="0" cellspacing="3" cellpadding="2" style="background: transparent;"><tr style="vertical-align: top;"><th style="width: 20em; text-align: left;">Id</th><td style="text-align: left;">1.2.40.0.34.10.170</td><th style="width: 20em; text-align: left;">Gültigkeit</th><td style="text-align: left;">2016‑11‑24</td></tr><tr style="vertical-align: top;"><th style="width: 20em; text-align: left;">Status</th><td style="text-align: left;">[[File:Kgreen.png|14px]] Definitiv</td><th style="width: 20em; text-align: left;">Versions-Label</th><td style="text-align: left;">4.0</td></tr><tr style="vertical-align: top;"><th style="width: 20em; text-align: left;">Name</th><td style="text-align: left;">ELGA_Antibiotika</td><th style="width: 20em; text-align: left;">Anzeigename</th><td style="text-align: left;">ELGA_Antibiotika</td></tr><tr class="headinglabel"><th style="vertical-align: top; text-align: left;">Quell-Codesystem</th><td colspan="3" class="tabtab"><div style="width: 100%; margin: 4px 0px; background-color: #fff;">2.16.840.1.113883.6.1 - <i>Logical Observation Identifier Names and Codes</i> - <i>http://loinc.org</i></div></td></tr><tr><td colspan="4" class="tabtab"><table class="treetable" width="100%" border="0" cellspacing="0" cellpadding="5" id="transactionTable" style="background: transparent;"><tr style="background-color: #F6F3EE;"><th style="text-align: left;">Level/ Typ</th><th style="width: 100px; text-align: left;">Code</th><th style="text-align: left;">Anzeigename</th><th style="width: 200px; text-align: left;">Codesystem</th></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">100-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefoperazone [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">101-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefoperazone [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">103-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ceforanide [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">104-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ceforanide [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">105-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ceforanide [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">10653-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Clotrimazole [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">10654-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Clotrimazole [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">10697-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Nystatin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">10698-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Nystatin [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">10720-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Terbinafine [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">10721-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Terbinafine [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">107-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefotaxime [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">108-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefotaxime [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">10868-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Bacitracin [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">109-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefotaxime [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">121-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefpodoxime [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">111-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefotetan [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">112-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefotetan [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">113-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefotetan [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">115-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefoxitin [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">11575-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefmetazole [Susceptibility] by Gradient strip</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">11576-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Erythromycin+Sulfisoxazole [Susceptibility] by Gradient strip</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">11577-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Sulfamethoxazole [Susceptibility] by Gradient strip</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">11578-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Sulfisoxazole [Susceptibility] by Gradient strip</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">116-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefoxitin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">11-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Amikacin [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">117-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefoxitin [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">129-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefsulodin [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">119-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefpodoxime [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">120-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefpodoxime [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">123-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefprozil [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">124-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefprozil [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">12-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Amikacin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">125-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefprozil [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">138-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ceftizoxime [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">127-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefsulodin [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">128-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefsulodin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">132-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ceftazidime [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">13-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Amikacin [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">133-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ceftazidime [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">134-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ceftazidime [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">136-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ceftizoxime [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">137-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ceftizoxime [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">13968-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Penicillin [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">140-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ceftriaxone [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">141-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ceftriaxone [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">142-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ceftriaxone [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">14332-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Para aminosalicylate [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">144-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefuroxime Parenteral [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">145-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefuroxime Parenteral [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">152-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cephaloglycin [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">146-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefuroxime Parenteral [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">148-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cephalexin [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">149-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cephalexin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">150-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cephalexin [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">153-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cephaloglycin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">154-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cephaloglycin [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">156-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cephaloridine [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">157-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cephaloridine [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">15-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Amoxicillin [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">158-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cephaloridine [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">160-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cephalothin [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">16099-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ethionamide [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">161-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cephalothin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">16100-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Rifabutin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">162-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cephalothin [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">16387-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Rifabutin+Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">16421-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Azithromycin+Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">164-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cephapirin [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">165-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cephapirin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">16-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Amoxicillin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">16620-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Clarithromycin+Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">16623-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Clofazimine [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">166-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cephapirin [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">16830-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Erythromycin+Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">16841-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ethambutol+Rifampin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">168-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cephradine [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">173-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Chloramphenicol [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">176-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Chlortetracycline [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">169-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cephradine [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">170-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cephradine [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">172-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Chloramphenicol [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">17-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Amoxicillin [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">174-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Chloramphenicol [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">177-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Chlortetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">178-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Chlortetracycline [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">182-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cinoxacin [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">1-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Acyclovir [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">180-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cinoxacin [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">181-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cinoxacin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18946-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Metronidazole [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18947-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Mezlocillin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18948-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Minocycline [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18949-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Miocamycin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18950-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Moxalactam [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18951-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Nafcillin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18952-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Nalidixate [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18953-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Neomycin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18954-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Netilmicin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18955-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Nitrofurantoin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18956-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Norfloxacin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18957-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Novobiocin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18958-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Nystatin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">184-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ciprofloxacin [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">198-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cloxacillin [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">185-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">186-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ciprofloxacin [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">188-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Clarithromycin [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18855-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">5-Fluorocytosine [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18857-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Almecillin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18859-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Amdinocillin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18860-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Amikacin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18861-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Amoxicillin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18862-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Amoxicillin+Clavulanate [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18863-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Amphotericin B [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18864-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ampicillin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18865-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ampicillin+Sulbactam [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18866-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Azithromycin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18867-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Azlocillin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18868-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Aztreonam [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18869-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Bacampicillin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18870-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Bacitracin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18871-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Butirosin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18872-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Capreomycin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18873-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Carbenicillin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18874-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefaclor [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18875-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefadroxil [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18876-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefamandole [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18877-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefatrizine [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18878-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefazolin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18879-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefepime [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18880-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefixime [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18881-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefmetazole [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18882-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefodizime [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18883-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefonicid [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18884-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefoperazone [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18885-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ceforanide [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18886-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefotaxime [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18887-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefotetan [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18888-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefoxitin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18889-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefpirome [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18890-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefpodoxime [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18891-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefprozil [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18892-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefsulodin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18893-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ceftazidime [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18894-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ceftizoxime [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18895-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ceftriaxone [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18896-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefuroxime Parenteral [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18897-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cephalexin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18898-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cephaloglycin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18899-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cephaloridine [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18900-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cephalothin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18901-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cephapirin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18902-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cephradine [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18903-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Chloramphenicol [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18904-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Chlortetracycline [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18905-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cinoxacin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18906-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ciprofloxacin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18907-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Clarithromycin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18908-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Clindamycin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18909-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Clotrimazole [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">189-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Clarithromycin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18910-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cloxacillin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18911-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Colistimethate</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18912-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Colistin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18913-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cyclacillin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18914-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cycloserine [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18915-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Demeclocycline [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18916-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Dicloxacillin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18917-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Doxycycline [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18918-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Enoxacin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18919-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Erythromycin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18920-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Erythromycin+Sulfisoxazole [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18921-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ethambutol [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18922-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ethionamide [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18923-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Floxacillin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18924-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Fluconazole [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18926-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Framycetin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18927-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Fusidate [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18928-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Gentamicin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18929-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Gentamicin.high potency [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18930-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Gramicidin D [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18931-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Hetacillin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18932-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Imipenem [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18934-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Isoniazid [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18935-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Kanamycin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18936-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Kanamycin.high potency [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18937-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ketoconazole [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18938-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Lincomycin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18939-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Lomefloxacin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18940-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Loracarbef [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18941-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Lymecycline [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18942-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Meclocycline [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18943-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Meropenem [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18944-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Methacycline [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18945-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Methicillin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18959-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ofloxacin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18960-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Oleandomycin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18961-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Oxacillin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18962-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Oxytetracycline [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18963-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Pefloxacin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18964-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Penicillin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18965-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Penicillin G [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18966-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Penicillin V [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18967-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Phenethicillin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18968-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Pipemidate [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18969-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Piperacillin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18970-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Piperacillin+Tazobactam [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18971-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Pivampicillin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18972-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Polymyxin B [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18973-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Pyrazinamide [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18974-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Rifampin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18975-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ristocetin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18976-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Rolitetracycline [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18977-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Rosoxacin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18978-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Roxithromycin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18979-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Sisomicin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18980-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Spectinomycin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18981-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Spiramycin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18982-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Streptomycin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18983-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Streptomycin.high potency [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18984-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Sulfadiazine [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18985-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Sulfamethoxazole [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18986-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Sulfisoxazole [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18987-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Sulfonamide [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18988-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Talampicillin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18989-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Teicoplanin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18990-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Temafloxacin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18991-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Temocillin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18992-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Terbinafine [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18993-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Tetracycline [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18994-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ticarcillin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18995-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ticarcillin+Clavulanate [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18996-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Tobramycin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18997-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Trimethoprim [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18998-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Trimethoprim+Sulfamethoxazole [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18999-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Troleandomycin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">19-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Amoxicillin+Clavulanate [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">19000-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Vancomycin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">19001-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Viomycin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">190-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Clarithromycin [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">19149-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Rifabutin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">192-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Clindamycin [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">193-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">194-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Clindamycin [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">20375-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Clarithromycin [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">20376-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Clofazimine [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">20377-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ciprofloxacin [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">20378-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ceftizoxime [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">20379-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Doxycycline [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">196-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cloxacillin [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">197-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cloxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">200-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Colistimethate by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">201-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Colistimethate by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">202-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Colistimethate by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">20373-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Amikacin [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">20374-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ampicillin+Sulbactam [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">20380-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Erythromycin [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">20381-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ethambutol [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">20382-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ethionamide [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">20383-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Isoniazid [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">20384-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ofloxacin [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">20385-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Rifampin [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">20386-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Rifabutin [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">20387-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Trimethoprim+Sulfamethoxazole [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">20388-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Nitrofurazone [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">20389-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Mupirocin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">20390-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Silver sulfadiazine [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">20391-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Mafenide [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">20396-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Levofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">20397-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Sparfloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">20460-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefuroxime Oral [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">20461-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Pyrazinamide [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">20462-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Streptomycin [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">204-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Colistin [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">205-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Colistin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">20629-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Levofloxacin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">206-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Colistin [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">209-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cyclacillin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">20-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Amoxicillin+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">208-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cyclacillin [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">210-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cyclacillin [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">21070-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Other Antibiotic [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">212-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cycloserine [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">21316-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Grepafloxacin [Susceptibility] by Gradient strip</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">21367-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Levofloxacin [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">213-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cycloserine [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">214-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cycloserine [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">21-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Amoxicillin+Clavulanate [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">216-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Demeclocycline [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">217-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Demeclocycline [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">23636-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefdinir [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">23637-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefdinir [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">23638-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Grepafloxacin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">23639-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Grepafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">23640-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Quinupristin+Dalfopristin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">218-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Demeclocycline [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">220-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Dicloxacillin [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">221-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Dicloxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">222-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Dicloxacillin [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">225-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Doxycycline [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">224-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Doxycycline [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">226-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Doxycycline [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">228-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Enoxacin [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">229-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Enoxacin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">230-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Enoxacin [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">23-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Amphotericin B [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">232-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Erythromycin [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">233-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">234-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Erythromycin [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">236-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Erythromycin+Sulfisoxazole [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">23607-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Capreomycin [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">23608-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cycloserine [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">23609-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Kanamycin [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">23610-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Sparfloxacin [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">23611-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Para aminosalicylate [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">23612-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Azithromycin [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">23613-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Imipenem [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">23614-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Trimethoprim [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">23615-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Vancomycin [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">23616-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Viomycin [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">23627-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Clofazimine [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">23628-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Sparfloxacin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">23629-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Para aminosalicylate [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">23641-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Quinupristin+Dalfopristin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">23642-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Trovafloxacin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">23643-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Trovafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">23658-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Other Antibiotic [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">23659-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Apramycin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">23709-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ceftiofur [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">23712-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Enrofloxacin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">23740-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Florfenicol [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">24-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Amphotericin B [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">237-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Erythromycin+Sulfisoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">238-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Erythromycin+Sulfisoxazole [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">23925-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Penicillin [Susceptibility] by Gradient strip</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">244-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Floxacillin [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">240-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ethambutol [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">241-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">242-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ethambutol [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">245-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Floxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">246-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Floxacillin [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">249-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Fluconazole [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">252-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">5-Fluorocytosine [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">248-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Fluconazole [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25452-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Itraconazole [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Amphotericin B [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">257-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Framycetin [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">250-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Fluconazole [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25174-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Amikacin 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25175-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Amikacin 16 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25176-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Amikacin 32 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25177-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Amikacin 12 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25178-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Amikacin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25179-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Amikacin 6 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25180-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ciprofloxacin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25181-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ciprofloxacin 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25182-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Kanamycin 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25183-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ethionamide 11 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25184-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Rifampin 14 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25185-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Streptomycin 6 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25186-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Pyrazinamide 25 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25187-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ethambutol 7.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25188-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ciprofloxacin 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25189-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ciprofloxacin 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25190-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Clarithromycin 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25191-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Clarithromycin 16 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25192-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Clarithromycin 32 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25194-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ethambutol 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25195-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ethambutol 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25196-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ethionamide 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25198-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ethionamide 15 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25199-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Rifabutin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25200-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Rifabutin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25201-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Rifabutin 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25202-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Rifampin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25203-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Rifampin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25204-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Rifampin 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25205-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Streptomycin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25206-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Streptomycin 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25207-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cycloserine 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25208-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cycloserine 20 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25209-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cycloserine 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25210-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Capreomycin 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25211-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Capreomycin 20 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25212-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Capreomycin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25213-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Kanamycin 6 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25214-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Kanamycin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25215-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Para aminosalicylate 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25216-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Para aminosalicylate 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25217-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Isoniazid 0.1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25218-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Isoniazid 0.2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25219-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Isoniazid 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25220-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefoxitin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25221-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Imipenem 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25222-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefmetazole 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25223-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Doxycycline 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25224-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Erythromycin 15 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25225-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Minocycline 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25226-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Sulfisoxazole 300 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25227-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Tobramycin 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25228-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Vancomycin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25229-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Pyrazinamide 100 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25230-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ethambutol 2.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25231-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ethionamide 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25310-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Amoxicillin+Clavulanate [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">253-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">5-Fluorocytosine [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25366-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefoxitin [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25367-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ceftriaxone [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25411-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Fleroxacin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">254-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">5-Fluorocytosine [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25595-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Econazole [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25596-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Fosfomycin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25597-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Josamycine [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25607-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Miconazole [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25608-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Nitroxoline [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25637-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Econazole [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25653-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Fosfomycin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">256-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Foscarnet [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25702-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Josamycine [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25722-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Miconazole [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25723-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Nitroxoline [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25800-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Tobramycin [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">258-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Framycetin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">259-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Framycetin [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">2-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Almecillin [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">274-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Hetacillin [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">261-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Fusidate [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">262-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Fusidate [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">263-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Fusidate [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">265-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ganciclovir [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">266-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Gentamicin [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">267-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">268-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Gentamicin [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">278-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Imipenem [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">270-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Gramicidin D [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">271-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Gramicidin D [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">272-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Gramicidin D [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">27-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ampicillin [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">276-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Hetacillin [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">275-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Hetacillin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">279-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Imipenem [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">280-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Imipenem [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">28-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ampicillin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">286-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Isoniazid [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">287-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Isoniazid [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">288-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Isoniazid [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">290-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Kanamycin [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">291-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Kanamycin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">292-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Kanamycin [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">29254-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">29255-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Linezolid [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">29258-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Linezolid [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">29315-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Isoniazid 0.4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">294-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ketoconazole [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">296-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ketoconazole [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">298-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Lincomycin [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">295-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ketoconazole [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">29-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ampicillin [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">299-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Lincomycin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">300-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Lincomycin [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">302-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Lomefloxacin [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">308-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Loracarbef [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30268-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Zidovudine [Susceptibility] by Phenotype method</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30269-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Lamivudine [Susceptibility] by Phenotype method</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30270-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Didanosine [Susceptibility] by Phenotype method</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30271-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Zalcitabine [Susceptibility] by Phenotype method</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30272-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Stavudine [Susceptibility] by Phenotype method</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30273-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Abacavir [Susceptibility] by Phenotype method</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30274-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Adefovir [Susceptibility] by Phenotype method</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30275-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Nevirapine [Susceptibility] by Phenotype method</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30276-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Delavirdine [Susceptibility] by Phenotype method</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30277-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Efavirenz [Susceptibility] by Phenotype method</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30278-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Indinavir [Susceptibility] by Phenotype method</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30279-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ritonavir [Susceptibility] by Phenotype method</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30280-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Nelfinavir [Susceptibility] by Phenotype method</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30281-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Saquinavir [Susceptibility] by Phenotype method</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30282-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Zidovudine [Susceptibility] by Genotype method</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30283-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Lamivudine [Susceptibility] by Genotype method</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30284-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Didanosine [Susceptibility] by Genotype method</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30285-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Zalcitabine [Susceptibility] by Genotype method</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30286-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Stavudine [Susceptibility] by Genotype method</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30287-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Abacavir [Susceptibility] by Genotype method</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30288-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Adefovir [Susceptibility] by Genotype method</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30289-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Nevirapine [Susceptibility] by Genotype method</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30290-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Delavirdine [Susceptibility] by Genotype method</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30291-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Efavirenz [Susceptibility] by Genotype method</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30292-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Indinavir [Susceptibility] by Genotype method</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30293-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ritonavir [Susceptibility] by Genotype method</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30294-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Nelfinavir [Susceptibility] by Genotype method</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30295-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Saquinavir [Susceptibility] by Genotype method</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30296-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Amprenavir [Susceptibility] by Phenotype method</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30297-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Amprenavir [Susceptibility] by Genotype method</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30298-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Lamivudine [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30299-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Amprenavir [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30300-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Didanosine [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30301-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Zalcitabine [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30302-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Stavudine [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30303-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Abacavir [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td colspan="4" style="background-color: #ffe6e6; border: 1px solid #ffcccc;">Dieses Value Set beinhaltet 1471 Codes. Um die Publikationsgröße überschaubar zu halten, wird nur eine Auswahl (500 Codes) des ganzen Sets von Codes gezeigt.</td></tr><tr><td colspan="4"><hr /></td></tr></table></td></tr><tr class="desclabel"><td colspan="4">Legende: Typ L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavors werden im @nullFlavor Attribut statt in @code angegeben. NullFlavor OTH (other) schlägt Text in originalText vor.</td></tr><tr class="noprint"><td colspan="4"><table class="artdecor" width="100%" border="0" cellspacing="3" cellpadding="2" style="background: transparent;"><tr><td style="width: 50px;"><img style=" max-width: 1em; max-height: 1em;" alt="download" src="https://art-decor.org/ADAR/rv/assets/download.png" title="Download" data-toggle="tooltip" data-placement="right" /></td><td style="text-align: left;" class="tabtab">XML JSON CSV SQL SVS </td></tr></table></td></tr></table>
+
<table xmlns="http://www.w3.org/1999/xhtml" class="artdecor" width="100%" border="0" cellspacing="3" cellpadding="2" style="background: transparent;"><tr style="vertical-align: top;"><th style="width: 20em; text-align: left;">Id</th><td style="text-align: left;">1.2.40.0.34.10.170</td><th style="width: 20em; text-align: left;">Gültigkeit</th><td style="text-align: left;">2016‑11‑24</td></tr><tr style="vertical-align: top;"><th style="width: 20em; text-align: left;">Status</th><td style="text-align: left;">[[File:Kgreen.png|14px]] Definitiv</td><th style="width: 20em; text-align: left;">Versions-Label</th><td style="text-align: left;">4.0</td></tr><tr style="vertical-align: top;"><th style="width: 20em; text-align: left;">Name</th><td style="text-align: left;">ELGA_Antibiotika</td><th style="width: 20em; text-align: left;">Anzeigename</th><td style="text-align: left;">ELGA_Antibiotika</td></tr><tr class="headinglabel"><th style="vertical-align: top; text-align: left;">Quell-Codesystem</th><td colspan="3" class="tabtab"><div style="width: 100%; margin: 4px 0px; background-color: #fff;">2.16.840.1.113883.6.1 - <i>Logical Observation Identifier Names and Codes</i> - <i>http://loinc.org</i></div></td></tr><tr><td colspan="4" class="tabtab"><table class="treetable" width="100%" border="0" cellspacing="0" cellpadding="5" id="transactionTable" style="background: transparent;"><tr style="background-color: #F6F3EE;"><th style="text-align: left;">Level/ Typ</th><th style="width: 100px; text-align: left;">Code</th><th style="text-align: left;">Anzeigename</th><th style="width: 200px; text-align: left;">Codesystem</th></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">100-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefoperazone [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">101-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefoperazone [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">103-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ceforanide [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">104-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ceforanide [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">105-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ceforanide [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">10653-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Clotrimazole [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">10654-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Clotrimazole [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">10697-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Nystatin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">10698-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Nystatin [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">10720-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Terbinafine [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">10721-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Terbinafine [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">107-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefotaxime [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">108-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefotaxime [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">10868-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Bacitracin [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">109-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefotaxime [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">121-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefpodoxime [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">111-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefotetan [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">112-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefotetan [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">113-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefotetan [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">115-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefoxitin [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">11575-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefmetazole [Susceptibility] by Gradient strip</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">11576-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Erythromycin+Sulfisoxazole [Susceptibility] by Gradient strip</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">11577-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Sulfamethoxazole [Susceptibility] by Gradient strip</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">11578-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Sulfisoxazole [Susceptibility] by Gradient strip</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">116-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefoxitin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">11-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Amikacin [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">117-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefoxitin [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">129-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefsulodin [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">119-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefpodoxime [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">120-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefpodoxime [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">123-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefprozil [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">124-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefprozil [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">12-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Amikacin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">125-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefprozil [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">138-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ceftizoxime [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">127-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefsulodin [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">128-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefsulodin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">132-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ceftazidime [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">13-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Amikacin [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">133-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ceftazidime [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">134-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ceftazidime [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">136-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ceftizoxime [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">137-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ceftizoxime [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">13968-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Penicillin [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">140-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ceftriaxone [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">141-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ceftriaxone [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">142-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ceftriaxone [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">14332-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Para aminosalicylate [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">144-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefuroxime Parenteral [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">145-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefuroxime Parenteral [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">152-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cephaloglycin [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">146-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefuroxime Parenteral [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">148-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cephalexin [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">149-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cephalexin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">150-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cephalexin [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">153-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cephaloglycin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">154-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cephaloglycin [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">156-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cephaloridine [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">157-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cephaloridine [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">15-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Amoxicillin [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">158-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cephaloridine [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">160-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cephalothin [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">16099-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ethionamide [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">161-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cephalothin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">16100-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Rifabutin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">162-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cephalothin [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">16387-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Rifabutin+Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">16421-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Azithromycin+Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">164-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cephapirin [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">165-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cephapirin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">16-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Amoxicillin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">16620-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Clarithromycin+Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">16623-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Clofazimine [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">166-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cephapirin [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">16830-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Erythromycin+Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">16841-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ethambutol+Rifampin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">168-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cephradine [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">173-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Chloramphenicol [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">176-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Chlortetracycline [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">169-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cephradine [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">170-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cephradine [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">172-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Chloramphenicol [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">17-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Amoxicillin [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">174-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Chloramphenicol [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">177-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Chlortetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">178-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Chlortetracycline [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">182-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cinoxacin [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">1-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Acyclovir [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">180-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cinoxacin [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">181-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cinoxacin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18946-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Metronidazole [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18947-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Mezlocillin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18948-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Minocycline [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18949-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Miocamycin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18950-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Moxalactam [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18951-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Nafcillin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18952-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Nalidixate [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18953-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Neomycin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18954-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Netilmicin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18955-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Nitrofurantoin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18956-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Norfloxacin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18957-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Novobiocin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18958-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Nystatin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">184-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ciprofloxacin [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">198-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cloxacillin [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">185-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">186-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ciprofloxacin [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">188-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Clarithromycin [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18855-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">5-Fluorocytosine [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18857-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Almecillin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18859-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Amdinocillin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18860-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Amikacin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18861-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Amoxicillin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18862-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Amoxicillin+Clavulanate [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18863-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Amphotericin B [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18864-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ampicillin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18865-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ampicillin+Sulbactam [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18866-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Azithromycin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18867-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Azlocillin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18868-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Aztreonam [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18869-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Bacampicillin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18870-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Bacitracin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18871-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Butirosin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18872-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Capreomycin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18873-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Carbenicillin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18874-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefaclor [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18875-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefadroxil [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18876-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefamandole [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18877-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefatrizine [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18878-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefazolin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18879-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefepime [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18880-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefixime [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18881-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefmetazole [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18882-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefodizime [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18883-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefonicid [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18884-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefoperazone [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18885-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ceforanide [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18886-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefotaxime [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18887-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefotetan [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18888-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefoxitin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18889-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefpirome [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18890-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefpodoxime [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18891-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefprozil [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18892-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefsulodin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18893-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ceftazidime [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18894-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ceftizoxime [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18895-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ceftriaxone [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18896-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefuroxime Parenteral [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18897-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cephalexin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18898-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cephaloglycin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18899-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cephaloridine [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18900-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cephalothin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18901-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cephapirin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18902-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cephradine [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18903-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Chloramphenicol [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18904-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Chlortetracycline [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18905-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cinoxacin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18906-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ciprofloxacin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18907-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Clarithromycin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18908-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Clindamycin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18909-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Clotrimazole [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">189-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Clarithromycin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18910-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cloxacillin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18911-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Colistimethate</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18912-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Colistin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18913-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cyclacillin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18914-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cycloserine [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18915-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Demeclocycline [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18916-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Dicloxacillin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18917-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Doxycycline [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18918-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Enoxacin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18919-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Erythromycin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18920-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Erythromycin+Sulfisoxazole [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18921-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ethambutol [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18922-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ethionamide [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18923-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Floxacillin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18924-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Fluconazole [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18926-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Framycetin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18927-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Fusidate [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18928-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Gentamicin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18929-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Gentamicin.high potency [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18930-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Gramicidin D [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18931-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Hetacillin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18932-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Imipenem [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18934-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Isoniazid [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18935-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Kanamycin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18936-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Kanamycin.high potency [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18937-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ketoconazole [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18938-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Lincomycin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18939-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Lomefloxacin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18940-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Loracarbef [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18941-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Lymecycline [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18942-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Meclocycline [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18943-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Meropenem [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18944-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Methacycline [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18945-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Methicillin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18959-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ofloxacin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18960-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Oleandomycin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18961-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Oxacillin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18962-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Oxytetracycline [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18963-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Pefloxacin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18964-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Penicillin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18965-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Penicillin G [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18966-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Penicillin V [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18967-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Phenethicillin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18968-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Pipemidate [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18969-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Piperacillin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18970-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Piperacillin+Tazobactam [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18971-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Pivampicillin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18972-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Polymyxin B [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18973-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Pyrazinamide [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18974-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Rifampin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18975-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ristocetin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18976-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Rolitetracycline [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18977-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Rosoxacin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18978-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Roxithromycin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18979-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Sisomicin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18980-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Spectinomycin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18981-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Spiramycin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18982-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Streptomycin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18983-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Streptomycin.high potency [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18984-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Sulfadiazine [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18985-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Sulfamethoxazole [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18986-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Sulfisoxazole [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18987-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Sulfonamide [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18988-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Talampicillin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18989-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Teicoplanin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18990-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Temafloxacin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18991-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Temocillin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18992-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Terbinafine [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18993-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Tetracycline [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18994-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ticarcillin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18995-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ticarcillin+Clavulanate [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18996-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Tobramycin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18997-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Trimethoprim [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18998-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Trimethoprim+Sulfamethoxazole [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">18999-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Troleandomycin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">19-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Amoxicillin+Clavulanate [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">19000-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Vancomycin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">19001-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Viomycin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">190-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Clarithromycin [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">19149-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Rifabutin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">192-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Clindamycin [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">193-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">194-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Clindamycin [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">20375-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Clarithromycin [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">20376-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Clofazimine [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">20377-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ciprofloxacin [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">20378-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ceftizoxime [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">20379-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Doxycycline [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">196-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cloxacillin [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">197-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cloxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">200-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Colistimethate by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">201-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Colistimethate by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">202-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Colistimethate by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">20373-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Amikacin [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">20374-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ampicillin+Sulbactam [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">20380-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Erythromycin [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">20381-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ethambutol [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">20382-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ethionamide [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">20383-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Isoniazid [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">20384-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ofloxacin [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">20385-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Rifampin [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">20386-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Rifabutin [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">20387-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Trimethoprim+Sulfamethoxazole [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">20388-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Nitrofurazone [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">20389-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Mupirocin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">20390-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Silver sulfadiazine [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">20391-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Mafenide [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">20396-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Levofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">20397-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Sparfloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">20460-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefuroxime Oral [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">20461-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Pyrazinamide [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">20462-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Streptomycin [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">204-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Colistin [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">205-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Colistin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">20629-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Levofloxacin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">206-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Colistin [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">209-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cyclacillin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">20-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Amoxicillin+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">208-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cyclacillin [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">210-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cyclacillin [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">21070-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Other Antibiotic [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">212-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cycloserine [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">21316-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Grepafloxacin [Susceptibility] by Gradient strip</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">21367-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Levofloxacin [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">213-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cycloserine [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">214-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cycloserine [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">21-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Amoxicillin+Clavulanate [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">216-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Demeclocycline [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">217-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Demeclocycline [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">23636-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefdinir [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">23637-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefdinir [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">23638-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Grepafloxacin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">23639-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Grepafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">23640-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Quinupristin+Dalfopristin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">218-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Demeclocycline [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">220-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Dicloxacillin [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">221-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Dicloxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">222-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Dicloxacillin [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">225-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Doxycycline [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">224-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Doxycycline [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">226-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Doxycycline [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">228-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Enoxacin [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">229-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Enoxacin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">230-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Enoxacin [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">23-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Amphotericin B [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">232-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Erythromycin [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">233-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">234-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Erythromycin [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">236-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Erythromycin+Sulfisoxazole [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">23607-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Capreomycin [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">23608-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cycloserine [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">23609-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Kanamycin [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">23610-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Sparfloxacin [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">23611-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Para aminosalicylate [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">23612-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Azithromycin [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">23613-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Imipenem [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">23614-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Trimethoprim [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">23615-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Vancomycin [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">23616-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Viomycin [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">23627-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Clofazimine [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">23628-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Sparfloxacin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">23629-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Para aminosalicylate [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">23641-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Quinupristin+Dalfopristin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">23642-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Trovafloxacin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">23643-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Trovafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">23658-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Other Antibiotic [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">23659-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Apramycin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">23709-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ceftiofur [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">23712-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Enrofloxacin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">23740-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Florfenicol [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">24-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Amphotericin B [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">237-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Erythromycin+Sulfisoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">238-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Erythromycin+Sulfisoxazole [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">23925-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Penicillin [Susceptibility] by Gradient strip</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">244-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Floxacillin [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">240-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ethambutol [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">241-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">242-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ethambutol [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">245-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Floxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">246-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Floxacillin [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">249-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Fluconazole [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">252-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">5-Fluorocytosine [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">248-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Fluconazole [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25452-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Itraconazole [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Amphotericin B [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">257-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Framycetin [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">250-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Fluconazole [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25174-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Amikacin 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25175-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Amikacin 16 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25176-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Amikacin 32 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25177-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Amikacin 12 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25178-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Amikacin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25179-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Amikacin 6 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25180-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ciprofloxacin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25181-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ciprofloxacin 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25182-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Kanamycin 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25183-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ethionamide 11 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25184-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Rifampin 14 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25185-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Streptomycin 6 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25186-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Pyrazinamide 25 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25187-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ethambutol 7.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25188-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ciprofloxacin 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25189-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ciprofloxacin 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25190-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Clarithromycin 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25191-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Clarithromycin 16 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25192-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Clarithromycin 32 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25194-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ethambutol 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25195-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ethambutol 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25196-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ethionamide 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25198-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ethionamide 15 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25199-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Rifabutin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25200-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Rifabutin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25201-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Rifabutin 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25202-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Rifampin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25203-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Rifampin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25204-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Rifampin 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25205-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Streptomycin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25206-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Streptomycin 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25207-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cycloserine 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25208-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cycloserine 20 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25209-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cycloserine 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25210-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Capreomycin 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25211-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Capreomycin 20 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25212-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Capreomycin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25213-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Kanamycin 6 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25214-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Kanamycin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25215-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Para aminosalicylate 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25216-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Para aminosalicylate 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25217-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Isoniazid 0.1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25218-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Isoniazid 0.2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25219-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Isoniazid 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25220-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefoxitin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25221-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Imipenem 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25222-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefmetazole 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25223-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Doxycycline 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25224-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Erythromycin 15 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25225-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Minocycline 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25226-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Sulfisoxazole 300 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25227-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Tobramycin 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25228-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Vancomycin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25229-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Pyrazinamide 100 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25230-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ethambutol 2.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25231-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ethionamide 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25310-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Amoxicillin+Clavulanate [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">253-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">5-Fluorocytosine [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25366-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Cefoxitin [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25367-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ceftriaxone [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25411-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Fleroxacin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">254-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">5-Fluorocytosine [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25595-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Econazole [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25596-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Fosfomycin [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25597-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Josamycine [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25607-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Miconazole [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25608-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Nitroxoline [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25637-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Econazole [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25653-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Fosfomycin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">256-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Foscarnet [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25702-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Josamycine [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25722-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Miconazole [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25723-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Nitroxoline [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">25800-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Tobramycin [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">258-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Framycetin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">259-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Framycetin [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">2-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Almecillin [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">274-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Hetacillin [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">261-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Fusidate [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">262-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Fusidate [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">263-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Fusidate [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">265-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ganciclovir [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">266-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Gentamicin [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">267-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">268-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Gentamicin [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">278-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Imipenem [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">270-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Gramicidin D [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">271-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Gramicidin D [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">272-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Gramicidin D [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">27-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ampicillin [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">276-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Hetacillin [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">275-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Hetacillin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">279-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Imipenem [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">280-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Imipenem [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">28-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ampicillin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">286-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Isoniazid [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">287-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Isoniazid [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">288-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Isoniazid [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">290-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Kanamycin [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">291-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Kanamycin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">292-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Kanamycin [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">29254-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">29255-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Linezolid [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">29258-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Linezolid [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">29315-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Isoniazid 0.4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">294-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ketoconazole [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">296-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ketoconazole [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">298-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Lincomycin [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">295-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ketoconazole [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">29-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ampicillin [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">299-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Lincomycin [Susceptibility] by Minimum inhibitory concentration (MIC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">300-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Lincomycin [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">302-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Lomefloxacin [Susceptibility] by Minimum lethal concentration (MLC)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">308-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Loracarbef [Susceptibility] by Disk diffusion (KB)</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30268-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Zidovudine [Susceptibility] by Phenotype method</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30269-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Lamivudine [Susceptibility] by Phenotype method</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30270-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Didanosine [Susceptibility] by Phenotype method</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30271-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Zalcitabine [Susceptibility] by Phenotype method</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30272-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Stavudine [Susceptibility] by Phenotype method</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30273-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Abacavir [Susceptibility] by Phenotype method</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30274-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Adefovir [Susceptibility] by Phenotype method</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30275-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Nevirapine [Susceptibility] by Phenotype method</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30276-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Delavirdine [Susceptibility] by Phenotype method</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30277-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Efavirenz [Susceptibility] by Phenotype method</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30278-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Indinavir [Susceptibility] by Phenotype method</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30279-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ritonavir [Susceptibility] by Phenotype method</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30280-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Nelfinavir [Susceptibility] by Phenotype method</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30281-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Saquinavir [Susceptibility] by Phenotype method</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30282-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Zidovudine [Susceptibility] by Genotype method</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30283-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Lamivudine [Susceptibility] by Genotype method</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30284-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Didanosine [Susceptibility] by Genotype method</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30285-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Zalcitabine [Susceptibility] by Genotype method</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30286-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Stavudine [Susceptibility] by Genotype method</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30287-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Abacavir [Susceptibility] by Genotype method</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30288-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Adefovir [Susceptibility] by Genotype method</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30289-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Nevirapine [Susceptibility] by Genotype method</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30290-1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Delavirdine [Susceptibility] by Genotype method</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30291-9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Efavirenz [Susceptibility] by Genotype method</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30292-7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Indinavir [Susceptibility] by Genotype method</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30293-5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Ritonavir [Susceptibility] by Genotype method</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30294-3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Nelfinavir [Susceptibility] by Genotype method</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30295-0</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Saquinavir [Susceptibility] by Genotype method</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30296-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Amprenavir [Susceptibility] by Phenotype method</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30297-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Amprenavir [Susceptibility] by Genotype method</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30298-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Lamivudine [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30299-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Amprenavir [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30300-8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Didanosine [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30301-6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Zalcitabine [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30302-4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Stavudine [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">30303-2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Abacavir [Susceptibility]</div></td><td style="vertical-align: top;">Logical Observation Identifier Names and Codes</td></tr><tr><td colspan="4" style="background-color: #ffe6e6; border: 1px solid #ffcccc;">Dieses Value Set beinhaltet 1471 Codes. Um die Publikationsgröße überschaubar zu halten, wird nur eine Auswahl (500 Codes) des ganzen Sets von Codes gezeigt.</td></tr><tr><td colspan="4"><hr /></td></tr></table></td></tr><tr class="desclabel"><td colspan="4">Legende: Typ L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavors werden im @nullFlavor Attribut statt in @code angegeben. NullFlavor OTH (other) schlägt Text in originalText vor.</td></tr></table>

Version vom 9. April 2020, 21:41 Uhr

Id1.2.40.0.34.10.170Gültigkeit2016‑11‑24
StatusKgreen.png DefinitivVersions-Label4.0
NameELGA_AntibiotikaAnzeigenameELGA_Antibiotika
Quell-Codesystem
2.16.840.1.113883.6.1 - Logical Observation Identifier Names and Codes - http://loinc.org
Level/ TypCodeAnzeigenameCodesystem
0‑L
100-8
Cefoperazone [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
101-6
Cefoperazone [Susceptibility] by Disk diffusion (KB)
Logical Observation Identifier Names and Codes
0‑L
103-2
Ceforanide [Susceptibility] by Minimum lethal concentration (MLC)
Logical Observation Identifier Names and Codes
0‑L
104-0
Ceforanide [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
105-7
Ceforanide [Susceptibility] by Disk diffusion (KB)
Logical Observation Identifier Names and Codes
0‑L
10653-4
Clotrimazole [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
10654-2
Clotrimazole [Susceptibility] by Minimum lethal concentration (MLC)
Logical Observation Identifier Names and Codes
0‑L
10697-1
Nystatin [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
10698-9
Nystatin [Susceptibility] by Minimum lethal concentration (MLC)
Logical Observation Identifier Names and Codes
0‑L
10720-1
Terbinafine [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
10721-9
Terbinafine [Susceptibility] by Minimum lethal concentration (MLC)
Logical Observation Identifier Names and Codes
0‑L
107-3
Cefotaxime [Susceptibility] by Minimum lethal concentration (MLC)
Logical Observation Identifier Names and Codes
0‑L
108-1
Cefotaxime [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
10868-8
Bacitracin [Susceptibility] by Disk diffusion (KB)
Logical Observation Identifier Names and Codes
0‑L
109-9
Cefotaxime [Susceptibility] by Disk diffusion (KB)
Logical Observation Identifier Names and Codes
0‑L
121-4
Cefpodoxime [Susceptibility] by Disk diffusion (KB)
Logical Observation Identifier Names and Codes
0‑L
111-5
Cefotetan [Susceptibility] by Minimum lethal concentration (MLC)
Logical Observation Identifier Names and Codes
0‑L
112-3
Cefotetan [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
113-1
Cefotetan [Susceptibility] by Disk diffusion (KB)
Logical Observation Identifier Names and Codes
0‑L
115-6
Cefoxitin [Susceptibility] by Minimum lethal concentration (MLC)
Logical Observation Identifier Names and Codes
0‑L
11575-8
Cefmetazole [Susceptibility] by Gradient strip
Logical Observation Identifier Names and Codes
0‑L
11576-6
Erythromycin+Sulfisoxazole [Susceptibility] by Gradient strip
Logical Observation Identifier Names and Codes
0‑L
11577-4
Sulfamethoxazole [Susceptibility] by Gradient strip
Logical Observation Identifier Names and Codes
0‑L
11578-2
Sulfisoxazole [Susceptibility] by Gradient strip
Logical Observation Identifier Names and Codes
0‑L
116-4
Cefoxitin [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
11-7
Amikacin [Susceptibility] by Minimum lethal concentration (MLC)
Logical Observation Identifier Names and Codes
0‑L
117-2
Cefoxitin [Susceptibility] by Disk diffusion (KB)
Logical Observation Identifier Names and Codes
0‑L
129-7
Cefsulodin [Susceptibility] by Disk diffusion (KB)
Logical Observation Identifier Names and Codes
0‑L
119-8
Cefpodoxime [Susceptibility] by Minimum lethal concentration (MLC)
Logical Observation Identifier Names and Codes
0‑L
120-6
Cefpodoxime [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
123-0
Cefprozil [Susceptibility] by Minimum lethal concentration (MLC)
Logical Observation Identifier Names and Codes
0‑L
124-8
Cefprozil [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
12-5
Amikacin [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
125-5
Cefprozil [Susceptibility] by Disk diffusion (KB)
Logical Observation Identifier Names and Codes
0‑L
138-8
Ceftizoxime [Susceptibility] by Disk diffusion (KB)
Logical Observation Identifier Names and Codes
0‑L
127-1
Cefsulodin [Susceptibility] by Minimum lethal concentration (MLC)
Logical Observation Identifier Names and Codes
0‑L
128-9
Cefsulodin [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
132-1
Ceftazidime [Susceptibility] by Minimum lethal concentration (MLC)
Logical Observation Identifier Names and Codes
0‑L
13-3
Amikacin [Susceptibility] by Disk diffusion (KB)
Logical Observation Identifier Names and Codes
0‑L
133-9
Ceftazidime [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
134-7
Ceftazidime [Susceptibility] by Disk diffusion (KB)
Logical Observation Identifier Names and Codes
0‑L
136-2
Ceftizoxime [Susceptibility] by Minimum lethal concentration (MLC)
Logical Observation Identifier Names and Codes
0‑L
137-0
Ceftizoxime [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
13968-3
Penicillin [Susceptibility] by Disk diffusion (KB)
Logical Observation Identifier Names and Codes
0‑L
140-4
Ceftriaxone [Susceptibility] by Minimum lethal concentration (MLC)
Logical Observation Identifier Names and Codes
0‑L
141-2
Ceftriaxone [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
142-0
Ceftriaxone [Susceptibility] by Disk diffusion (KB)
Logical Observation Identifier Names and Codes
0‑L
14332-1
Para aminosalicylate [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
144-6
Cefuroxime Parenteral [Susceptibility] by Minimum lethal concentration (MLC)
Logical Observation Identifier Names and Codes
0‑L
145-3
Cefuroxime Parenteral [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
152-9
Cephaloglycin [Susceptibility] by Minimum lethal concentration (MLC)
Logical Observation Identifier Names and Codes
0‑L
146-1
Cefuroxime Parenteral [Susceptibility] by Disk diffusion (KB)
Logical Observation Identifier Names and Codes
0‑L
148-7
Cephalexin [Susceptibility] by Minimum lethal concentration (MLC)
Logical Observation Identifier Names and Codes
0‑L
149-5
Cephalexin [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
150-3
Cephalexin [Susceptibility] by Disk diffusion (KB)
Logical Observation Identifier Names and Codes
0‑L
153-7
Cephaloglycin [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
154-5
Cephaloglycin [Susceptibility] by Disk diffusion (KB)
Logical Observation Identifier Names and Codes
0‑L
156-0
Cephaloridine [Susceptibility] by Minimum lethal concentration (MLC)
Logical Observation Identifier Names and Codes
0‑L
157-8
Cephaloridine [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
15-8
Amoxicillin [Susceptibility] by Minimum lethal concentration (MLC)
Logical Observation Identifier Names and Codes
0‑L
158-6
Cephaloridine [Susceptibility] by Disk diffusion (KB)
Logical Observation Identifier Names and Codes
0‑L
160-2
Cephalothin [Susceptibility] by Minimum lethal concentration (MLC)
Logical Observation Identifier Names and Codes
0‑L
16099-4
Ethionamide [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
161-0
Cephalothin [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
16100-0
Rifabutin [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
162-8
Cephalothin [Susceptibility] by Disk diffusion (KB)
Logical Observation Identifier Names and Codes
0‑L
16387-3
Rifabutin+Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
16421-0
Azithromycin+Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
164-4
Cephapirin [Susceptibility] by Minimum lethal concentration (MLC)
Logical Observation Identifier Names and Codes
0‑L
165-1
Cephapirin [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
16-6
Amoxicillin [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
16620-7
Clarithromycin+Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
16623-1
Clofazimine [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
166-9
Cephapirin [Susceptibility] by Disk diffusion (KB)
Logical Observation Identifier Names and Codes
0‑L
16830-2
Erythromycin+Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
16841-9
Ethambutol+Rifampin [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
168-5
Cephradine [Susceptibility] by Minimum lethal concentration (MLC)
Logical Observation Identifier Names and Codes
0‑L
173-5
Chloramphenicol [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
176-8
Chlortetracycline [Susceptibility] by Minimum lethal concentration (MLC)
Logical Observation Identifier Names and Codes
0‑L
169-3
Cephradine [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
170-1
Cephradine [Susceptibility] by Disk diffusion (KB)
Logical Observation Identifier Names and Codes
0‑L
172-7
Chloramphenicol [Susceptibility] by Minimum lethal concentration (MLC)
Logical Observation Identifier Names and Codes
0‑L
17-4
Amoxicillin [Susceptibility] by Disk diffusion (KB)
Logical Observation Identifier Names and Codes
0‑L
174-3
Chloramphenicol [Susceptibility] by Disk diffusion (KB)
Logical Observation Identifier Names and Codes
0‑L
177-6
Chlortetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
178-4
Chlortetracycline [Susceptibility] by Disk diffusion (KB)
Logical Observation Identifier Names and Codes
0‑L
182-6
Cinoxacin [Susceptibility] by Disk diffusion (KB)
Logical Observation Identifier Names and Codes
0‑L
1-8
Acyclovir [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
180-0
Cinoxacin [Susceptibility] by Minimum lethal concentration (MLC)
Logical Observation Identifier Names and Codes
0‑L
181-8
Cinoxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
18946-4
Metronidazole [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18947-2
Mezlocillin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18948-0
Minocycline [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18949-8
Miocamycin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18950-6
Moxalactam [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18951-4
Nafcillin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18952-2
Nalidixate [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18953-0
Neomycin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18954-8
Netilmicin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18955-5
Nitrofurantoin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18956-3
Norfloxacin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18957-1
Novobiocin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18958-9
Nystatin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
184-2
Ciprofloxacin [Susceptibility] by Minimum lethal concentration (MLC)
Logical Observation Identifier Names and Codes
0‑L
198-2
Cloxacillin [Susceptibility] by Disk diffusion (KB)
Logical Observation Identifier Names and Codes
0‑L
185-9
Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
186-7
Ciprofloxacin [Susceptibility] by Disk diffusion (KB)
Logical Observation Identifier Names and Codes
0‑L
188-3
Clarithromycin [Susceptibility] by Minimum lethal concentration (MLC)
Logical Observation Identifier Names and Codes
0‑L
18855-7
5-Fluorocytosine [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18857-3
Almecillin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18859-9
Amdinocillin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18860-7
Amikacin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18861-5
Amoxicillin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18862-3
Amoxicillin+Clavulanate [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18863-1
Amphotericin B [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18864-9
Ampicillin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18865-6
Ampicillin+Sulbactam [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18866-4
Azithromycin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18867-2
Azlocillin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18868-0
Aztreonam [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18869-8
Bacampicillin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18870-6
Bacitracin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18871-4
Butirosin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18872-2
Capreomycin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18873-0
Carbenicillin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18874-8
Cefaclor [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18875-5
Cefadroxil [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18876-3
Cefamandole [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18877-1
Cefatrizine [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18878-9
Cefazolin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18879-7
Cefepime [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18880-5
Cefixime [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18881-3
Cefmetazole [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18882-1
Cefodizime [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18883-9
Cefonicid [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18884-7
Cefoperazone [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18885-4
Ceforanide [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18886-2
Cefotaxime [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18887-0
Cefotetan [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18888-8
Cefoxitin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18889-6
Cefpirome [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18890-4
Cefpodoxime [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18891-2
Cefprozil [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18892-0
Cefsulodin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18893-8
Ceftazidime [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18894-6
Ceftizoxime [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18895-3
Ceftriaxone [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18896-1
Cefuroxime Parenteral [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18897-9
Cephalexin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18898-7
Cephaloglycin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18899-5
Cephaloridine [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18900-1
Cephalothin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18901-9
Cephapirin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18902-7
Cephradine [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18903-5
Chloramphenicol [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18904-3
Chlortetracycline [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18905-0
Cinoxacin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18906-8
Ciprofloxacin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18907-6
Clarithromycin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18908-4
Clindamycin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18909-2
Clotrimazole [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
189-1
Clarithromycin [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
18910-0
Cloxacillin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18911-8
Colistimethate
Logical Observation Identifier Names and Codes
0‑L
18912-6
Colistin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18913-4
Cyclacillin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18914-2
Cycloserine [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18915-9
Demeclocycline [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18916-7
Dicloxacillin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18917-5
Doxycycline [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18918-3
Enoxacin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18919-1
Erythromycin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18920-9
Erythromycin+Sulfisoxazole [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18921-7
Ethambutol [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18922-5
Ethionamide [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18923-3
Floxacillin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18924-1
Fluconazole [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18926-6
Framycetin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18927-4
Fusidate [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18928-2
Gentamicin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18929-0
Gentamicin.high potency [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18930-8
Gramicidin D [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18931-6
Hetacillin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18932-4
Imipenem [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18934-0
Isoniazid [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18935-7
Kanamycin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18936-5
Kanamycin.high potency [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18937-3
Ketoconazole [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18938-1
Lincomycin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18939-9
Lomefloxacin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18940-7
Loracarbef [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18941-5
Lymecycline [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18942-3
Meclocycline [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18943-1
Meropenem [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18944-9
Methacycline [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18945-6
Methicillin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18959-7
Ofloxacin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18960-5
Oleandomycin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18961-3
Oxacillin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18962-1
Oxytetracycline [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18963-9
Pefloxacin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18964-7
Penicillin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18965-4
Penicillin G [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18966-2
Penicillin V [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18967-0
Phenethicillin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18968-8
Pipemidate [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18969-6
Piperacillin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18970-4
Piperacillin+Tazobactam [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18971-2
Pivampicillin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18972-0
Polymyxin B [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18973-8
Pyrazinamide [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18974-6
Rifampin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18975-3
Ristocetin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18976-1
Rolitetracycline [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18977-9
Rosoxacin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18978-7
Roxithromycin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18979-5
Sisomicin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18980-3
Spectinomycin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18981-1
Spiramycin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18982-9
Streptomycin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18983-7
Streptomycin.high potency [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18984-5
Sulfadiazine [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18985-2
Sulfamethoxazole [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18986-0
Sulfisoxazole [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18987-8
Sulfonamide [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18988-6
Talampicillin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18989-4
Teicoplanin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18990-2
Temafloxacin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18991-0
Temocillin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18992-8
Terbinafine [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18993-6
Tetracycline [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18994-4
Ticarcillin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18995-1
Ticarcillin+Clavulanate [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18996-9
Tobramycin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18997-7
Trimethoprim [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18998-5
Trimethoprim+Sulfamethoxazole [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
18999-3
Troleandomycin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
19-0
Amoxicillin+Clavulanate [Susceptibility] by Minimum lethal concentration (MLC)
Logical Observation Identifier Names and Codes
0‑L
19000-9
Vancomycin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
19001-7
Viomycin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
190-9
Clarithromycin [Susceptibility] by Disk diffusion (KB)
Logical Observation Identifier Names and Codes
0‑L
19149-4
Rifabutin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
192-5
Clindamycin [Susceptibility] by Minimum lethal concentration (MLC)
Logical Observation Identifier Names and Codes
0‑L
193-3
Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
194-1
Clindamycin [Susceptibility] by Disk diffusion (KB)
Logical Observation Identifier Names and Codes
0‑L
20375-2
Clarithromycin [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
20376-0
Clofazimine [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
20377-8
Ciprofloxacin [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
20378-6
Ceftizoxime [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
20379-4
Doxycycline [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
196-6
Cloxacillin [Susceptibility] by Minimum lethal concentration (MLC)
Logical Observation Identifier Names and Codes
0‑L
197-4
Cloxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
200-6
Colistimethate by Minimum lethal concentration (MLC)
Logical Observation Identifier Names and Codes
0‑L
201-4
Colistimethate by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
202-2
Colistimethate by Disk diffusion (KB)
Logical Observation Identifier Names and Codes
0‑L
20373-7
Amikacin [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
20374-5
Ampicillin+Sulbactam [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
20380-2
Erythromycin [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
20381-0
Ethambutol [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
20382-8
Ethionamide [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
20383-6
Isoniazid [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
20384-4
Ofloxacin [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
20385-1
Rifampin [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
20386-9
Rifabutin [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
20387-7
Trimethoprim+Sulfamethoxazole [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
20388-5
Nitrofurazone [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
20389-3
Mupirocin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
20390-1
Silver sulfadiazine [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
20391-9
Mafenide [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
20396-8
Levofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
20397-6
Sparfloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
20460-2
Cefuroxime Oral [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
20461-0
Pyrazinamide [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
20462-8
Streptomycin [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
204-8
Colistin [Susceptibility] by Minimum lethal concentration (MLC)
Logical Observation Identifier Names and Codes
0‑L
205-5
Colistin [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
20629-2
Levofloxacin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
206-3
Colistin [Susceptibility] by Disk diffusion (KB)
Logical Observation Identifier Names and Codes
0‑L
209-7
Cyclacillin [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
20-8
Amoxicillin+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
208-9
Cyclacillin [Susceptibility] by Minimum lethal concentration (MLC)
Logical Observation Identifier Names and Codes
0‑L
210-5
Cyclacillin [Susceptibility] by Disk diffusion (KB)
Logical Observation Identifier Names and Codes
0‑L
21070-8
Other Antibiotic [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
212-1
Cycloserine [Susceptibility] by Minimum lethal concentration (MLC)
Logical Observation Identifier Names and Codes
0‑L
21316-5
Grepafloxacin [Susceptibility] by Gradient strip
Logical Observation Identifier Names and Codes
0‑L
21367-8
Levofloxacin [Susceptibility] by Disk diffusion (KB)
Logical Observation Identifier Names and Codes
0‑L
213-9
Cycloserine [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
214-7
Cycloserine [Susceptibility] by Disk diffusion (KB)
Logical Observation Identifier Names and Codes
0‑L
21-6
Amoxicillin+Clavulanate [Susceptibility] by Disk diffusion (KB)
Logical Observation Identifier Names and Codes
0‑L
216-2
Demeclocycline [Susceptibility] by Minimum lethal concentration (MLC)
Logical Observation Identifier Names and Codes
0‑L
217-0
Demeclocycline [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
23636-4
Cefdinir [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
23637-2
Cefdinir [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
23638-0
Grepafloxacin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
23639-8
Grepafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
23640-6
Quinupristin+Dalfopristin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
218-8
Demeclocycline [Susceptibility] by Disk diffusion (KB)
Logical Observation Identifier Names and Codes
0‑L
220-4
Dicloxacillin [Susceptibility] by Minimum lethal concentration (MLC)
Logical Observation Identifier Names and Codes
0‑L
221-2
Dicloxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
222-0
Dicloxacillin [Susceptibility] by Disk diffusion (KB)
Logical Observation Identifier Names and Codes
0‑L
225-3
Doxycycline [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
224-6
Doxycycline [Susceptibility] by Minimum lethal concentration (MLC)
Logical Observation Identifier Names and Codes
0‑L
226-1
Doxycycline [Susceptibility] by Disk diffusion (KB)
Logical Observation Identifier Names and Codes
0‑L
228-7
Enoxacin [Susceptibility] by Minimum lethal concentration (MLC)
Logical Observation Identifier Names and Codes
0‑L
229-5
Enoxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
230-3
Enoxacin [Susceptibility] by Disk diffusion (KB)
Logical Observation Identifier Names and Codes
0‑L
23-2
Amphotericin B [Susceptibility] by Minimum lethal concentration (MLC)
Logical Observation Identifier Names and Codes
0‑L
232-9
Erythromycin [Susceptibility] by Minimum lethal concentration (MLC)
Logical Observation Identifier Names and Codes
0‑L
233-7
Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
234-5
Erythromycin [Susceptibility] by Disk diffusion (KB)
Logical Observation Identifier Names and Codes
0‑L
236-0
Erythromycin+Sulfisoxazole [Susceptibility] by Minimum lethal concentration (MLC)
Logical Observation Identifier Names and Codes
0‑L
23607-5
Capreomycin [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
23608-3
Cycloserine [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
23609-1
Kanamycin [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
23610-9
Sparfloxacin [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
23611-7
Para aminosalicylate [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
23612-5
Azithromycin [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
23613-3
Imipenem [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
23614-1
Trimethoprim [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
23615-8
Vancomycin [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
23616-6
Viomycin [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
23627-3
Clofazimine [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
23628-1
Sparfloxacin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
23629-9
Para aminosalicylate [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
23641-4
Quinupristin+Dalfopristin [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
23642-2
Trovafloxacin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
23643-0
Trovafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
23658-8
Other Antibiotic [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
23659-6
Apramycin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
23709-9
Ceftiofur [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
23712-3
Enrofloxacin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
23740-4
Florfenicol [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
24-0
Amphotericin B [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
237-8
Erythromycin+Sulfisoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
238-6
Erythromycin+Sulfisoxazole [Susceptibility] by Disk diffusion (KB)
Logical Observation Identifier Names and Codes
0‑L
23925-1
Penicillin [Susceptibility] by Gradient strip
Logical Observation Identifier Names and Codes
0‑L
244-4
Floxacillin [Susceptibility] by Minimum lethal concentration (MLC)
Logical Observation Identifier Names and Codes
0‑L
240-2
Ethambutol [Susceptibility] by Minimum lethal concentration (MLC)
Logical Observation Identifier Names and Codes
0‑L
241-0
Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
242-8
Ethambutol [Susceptibility] by Disk diffusion (KB)
Logical Observation Identifier Names and Codes
0‑L
245-1
Floxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
246-9
Floxacillin [Susceptibility] by Disk diffusion (KB)
Logical Observation Identifier Names and Codes
0‑L
249-3
Fluconazole [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
252-7
5-Fluorocytosine [Susceptibility] by Minimum lethal concentration (MLC)
Logical Observation Identifier Names and Codes
0‑L
248-5
Fluconazole [Susceptibility] by Minimum lethal concentration (MLC)
Logical Observation Identifier Names and Codes
0‑L
25452-4
Itraconazole [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
25-7
Amphotericin B [Susceptibility] by Disk diffusion (KB)
Logical Observation Identifier Names and Codes
0‑L
257-6
Framycetin [Susceptibility] by Minimum lethal concentration (MLC)
Logical Observation Identifier Names and Codes
0‑L
250-1
Fluconazole [Susceptibility] by Disk diffusion (KB)
Logical Observation Identifier Names and Codes
0‑L
25174-4
Amikacin 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
25175-1
Amikacin 16 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
25176-9
Amikacin 32 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
25177-7
Amikacin 12 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
25178-5
Amikacin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
25179-3
Amikacin 6 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
25180-1
Ciprofloxacin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
25181-9
Ciprofloxacin 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
25182-7
Kanamycin 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
25183-5
Ethionamide 11 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
25184-3
Rifampin 14 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
25185-0
Streptomycin 6 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
25186-8
Pyrazinamide 25 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
25187-6
Ethambutol 7.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
25188-4
Ciprofloxacin 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
25189-2
Ciprofloxacin 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
25190-0
Clarithromycin 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
25191-8
Clarithromycin 16 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
25192-6
Clarithromycin 32 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
25194-2
Ethambutol 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
25195-9
Ethambutol 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
25196-7
Ethionamide 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
25198-3
Ethionamide 15 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
25199-1
Rifabutin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
25200-7
Rifabutin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
25201-5
Rifabutin 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
25202-3
Rifampin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
25203-1
Rifampin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
25204-9
Rifampin 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
25205-6
Streptomycin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
25206-4
Streptomycin 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
25207-2
Cycloserine 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
25208-0
Cycloserine 20 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
25209-8
Cycloserine 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
25210-6
Capreomycin 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
25211-4
Capreomycin 20 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
25212-2
Capreomycin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
25213-0
Kanamycin 6 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
25214-8
Kanamycin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
25215-5
Para aminosalicylate 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
25216-3
Para aminosalicylate 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
25217-1
Isoniazid 0.1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
25218-9
Isoniazid 0.2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
25219-7
Isoniazid 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
25220-5
Cefoxitin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
25221-3
Imipenem 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
25222-1
Cefmetazole 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
25223-9
Doxycycline 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
25224-7
Erythromycin 15 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
25225-4
Minocycline 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
25226-2
Sulfisoxazole 300 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
25227-0
Tobramycin 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
25228-8
Vancomycin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
25229-6
Pyrazinamide 100 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
25230-4
Ethambutol 2.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
25231-2
Ethionamide 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
25310-4
Amoxicillin+Clavulanate [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
253-5
5-Fluorocytosine [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
25366-6
Cefoxitin [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
25367-4
Ceftriaxone [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
25411-0
Fleroxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
254-3
5-Fluorocytosine [Susceptibility] by Disk diffusion (KB)
Logical Observation Identifier Names and Codes
0‑L
25595-0
Econazole [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
25596-8
Fosfomycin [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
25597-6
Josamycine [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
25607-3
Miconazole [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
25608-1
Nitroxoline [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
25637-0
Econazole [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
25653-7
Fosfomycin [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
256-8
Foscarnet [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
25702-2
Josamycine [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
25722-0
Miconazole [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
25723-8
Nitroxoline [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
25800-4
Tobramycin [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
258-4
Framycetin [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
259-2
Framycetin [Susceptibility] by Disk diffusion (KB)
Logical Observation Identifier Names and Codes
0‑L
2-6
Almecillin [Susceptibility] by Minimum lethal concentration (MLC)
Logical Observation Identifier Names and Codes
0‑L
274-1
Hetacillin [Susceptibility] by Minimum lethal concentration (MLC)
Logical Observation Identifier Names and Codes
0‑L
261-8
Fusidate [Susceptibility] by Minimum lethal concentration (MLC)
Logical Observation Identifier Names and Codes
0‑L
262-6
Fusidate [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
263-4
Fusidate [Susceptibility] by Disk diffusion (KB)
Logical Observation Identifier Names and Codes
0‑L
265-9
Ganciclovir [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
266-7
Gentamicin [Susceptibility] by Minimum lethal concentration (MLC)
Logical Observation Identifier Names and Codes
0‑L
267-5
Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
268-3
Gentamicin [Susceptibility] by Disk diffusion (KB)
Logical Observation Identifier Names and Codes
0‑L
278-2
Imipenem [Susceptibility] by Minimum lethal concentration (MLC)
Logical Observation Identifier Names and Codes
0‑L
270-9
Gramicidin D [Susceptibility] by Minimum lethal concentration (MLC)
Logical Observation Identifier Names and Codes
0‑L
271-7
Gramicidin D [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
272-5
Gramicidin D [Susceptibility] by Disk diffusion (KB)
Logical Observation Identifier Names and Codes
0‑L
27-3
Ampicillin [Susceptibility] by Minimum lethal concentration (MLC)
Logical Observation Identifier Names and Codes
0‑L
276-6
Hetacillin [Susceptibility] by Disk diffusion (KB)
Logical Observation Identifier Names and Codes
0‑L
275-8
Hetacillin [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
279-0
Imipenem [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
280-8
Imipenem [Susceptibility] by Disk diffusion (KB)
Logical Observation Identifier Names and Codes
0‑L
28-1
Ampicillin [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
286-5
Isoniazid [Susceptibility] by Minimum lethal concentration (MLC)
Logical Observation Identifier Names and Codes
0‑L
287-3
Isoniazid [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
288-1
Isoniazid [Susceptibility] by Disk diffusion (KB)
Logical Observation Identifier Names and Codes
0‑L
290-7
Kanamycin [Susceptibility] by Minimum lethal concentration (MLC)
Logical Observation Identifier Names and Codes
0‑L
291-5
Kanamycin [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
292-3
Kanamycin [Susceptibility] by Disk diffusion (KB)
Logical Observation Identifier Names and Codes
0‑L
29254-0
Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
29255-7
Linezolid [Susceptibility] by Disk diffusion (KB)
Logical Observation Identifier Names and Codes
0‑L
29258-1
Linezolid [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
29315-9
Isoniazid 0.4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Logical Observation Identifier Names and Codes
0‑L
294-9
Ketoconazole [Susceptibility] by Minimum lethal concentration (MLC)
Logical Observation Identifier Names and Codes
0‑L
296-4
Ketoconazole [Susceptibility] by Disk diffusion (KB)
Logical Observation Identifier Names and Codes
0‑L
298-0
Lincomycin [Susceptibility] by Minimum lethal concentration (MLC)
Logical Observation Identifier Names and Codes
0‑L
295-6
Ketoconazole [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
29-9
Ampicillin [Susceptibility] by Disk diffusion (KB)
Logical Observation Identifier Names and Codes
0‑L
299-8
Lincomycin [Susceptibility] by Minimum inhibitory concentration (MIC)
Logical Observation Identifier Names and Codes
0‑L
300-4
Lincomycin [Susceptibility] by Disk diffusion (KB)
Logical Observation Identifier Names and Codes
0‑L
302-0
Lomefloxacin [Susceptibility] by Minimum lethal concentration (MLC)
Logical Observation Identifier Names and Codes
0‑L
308-7
Loracarbef [Susceptibility] by Disk diffusion (KB)
Logical Observation Identifier Names and Codes
0‑L
30268-7
Zidovudine [Susceptibility] by Phenotype method
Logical Observation Identifier Names and Codes
0‑L
30269-5
Lamivudine [Susceptibility] by Phenotype method
Logical Observation Identifier Names and Codes
0‑L
30270-3
Didanosine [Susceptibility] by Phenotype method
Logical Observation Identifier Names and Codes
0‑L
30271-1
Zalcitabine [Susceptibility] by Phenotype method
Logical Observation Identifier Names and Codes
0‑L
30272-9
Stavudine [Susceptibility] by Phenotype method
Logical Observation Identifier Names and Codes
0‑L
30273-7
Abacavir [Susceptibility] by Phenotype method
Logical Observation Identifier Names and Codes
0‑L
30274-5
Adefovir [Susceptibility] by Phenotype method
Logical Observation Identifier Names and Codes
0‑L
30275-2
Nevirapine [Susceptibility] by Phenotype method
Logical Observation Identifier Names and Codes
0‑L
30276-0
Delavirdine [Susceptibility] by Phenotype method
Logical Observation Identifier Names and Codes
0‑L
30277-8
Efavirenz [Susceptibility] by Phenotype method
Logical Observation Identifier Names and Codes
0‑L
30278-6
Indinavir [Susceptibility] by Phenotype method
Logical Observation Identifier Names and Codes
0‑L
30279-4
Ritonavir [Susceptibility] by Phenotype method
Logical Observation Identifier Names and Codes
0‑L
30280-2
Nelfinavir [Susceptibility] by Phenotype method
Logical Observation Identifier Names and Codes
0‑L
30281-0
Saquinavir [Susceptibility] by Phenotype method
Logical Observation Identifier Names and Codes
0‑L
30282-8
Zidovudine [Susceptibility] by Genotype method
Logical Observation Identifier Names and Codes
0‑L
30283-6
Lamivudine [Susceptibility] by Genotype method
Logical Observation Identifier Names and Codes
0‑L
30284-4
Didanosine [Susceptibility] by Genotype method
Logical Observation Identifier Names and Codes
0‑L
30285-1
Zalcitabine [Susceptibility] by Genotype method
Logical Observation Identifier Names and Codes
0‑L
30286-9
Stavudine [Susceptibility] by Genotype method
Logical Observation Identifier Names and Codes
0‑L
30287-7
Abacavir [Susceptibility] by Genotype method
Logical Observation Identifier Names and Codes
0‑L
30288-5
Adefovir [Susceptibility] by Genotype method
Logical Observation Identifier Names and Codes
0‑L
30289-3
Nevirapine [Susceptibility] by Genotype method
Logical Observation Identifier Names and Codes
0‑L
30290-1
Delavirdine [Susceptibility] by Genotype method
Logical Observation Identifier Names and Codes
0‑L
30291-9
Efavirenz [Susceptibility] by Genotype method
Logical Observation Identifier Names and Codes
0‑L
30292-7
Indinavir [Susceptibility] by Genotype method
Logical Observation Identifier Names and Codes
0‑L
30293-5
Ritonavir [Susceptibility] by Genotype method
Logical Observation Identifier Names and Codes
0‑L
30294-3
Nelfinavir [Susceptibility] by Genotype method
Logical Observation Identifier Names and Codes
0‑L
30295-0
Saquinavir [Susceptibility] by Genotype method
Logical Observation Identifier Names and Codes
0‑L
30296-8
Amprenavir [Susceptibility] by Phenotype method
Logical Observation Identifier Names and Codes
0‑L
30297-6
Amprenavir [Susceptibility] by Genotype method
Logical Observation Identifier Names and Codes
0‑L
30298-4
Lamivudine [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
30299-2
Amprenavir [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
30300-8
Didanosine [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
30301-6
Zalcitabine [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
30302-4
Stavudine [Susceptibility]
Logical Observation Identifier Names and Codes
0‑L
30303-2
Abacavir [Susceptibility]
Logical Observation Identifier Names and Codes
Dieses Value Set beinhaltet 1471 Codes. Um die Publikationsgröße überschaubar zu halten, wird nur eine Auswahl (500 Codes) des ganzen Sets von Codes gezeigt.
Legende: Typ L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavors werden im @nullFlavor Attribut statt in @code angegeben. NullFlavor OTH (other) schlägt Text in originalText vor.
Abgerufen von „http://wiki.hl7.at/index.php?title=1.2.40.0.34.10.170/static-2016-11-24T000000&oldid=116791“